Welcome to our dedicated page for Healthpeak Properties SEC filings (Ticker: DOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthpeak Properties, Inc. filings document the regulatory record of a Maryland REIT focused on healthcare discovery and delivery real estate. Form 8-K reports furnish quarterly and annual financial results, supplemental operating information, Regulation FD materials, non-GAAP reconciliations, and material agreements tied to credit facilities and other financing activity.
Proxy and annual-meeting filings describe board elections, shareholder voting results, executive compensation, and governance matters. The filing record also covers capital-structure disclosures for Healthpeak and Healthpeak OP, including unsecured term loan amendments, delayed-draw financing, senior notes, and related subsidiary financing activity.
Vanguard Capital Management reported beneficial ownership of 51,643,591 shares of Healthpeak Properties Inc Common Stock. The filing states this equals 7.42% of the class and shows sole dispositive power for 51,643,591 shares and sole voting power for 6,424,664 shares.
Vanguard Portfolio Management reports beneficial ownership of 58,209,788 shares of Healthpeak Properties Inc common stock, representing 8.37% of the class as reported for the period ended 03/31/2026. Vanguard discloses sole dispositive power over those 58,209,788 shares and sole voting power for 83,889 shares. The filing states these holdings include securities held for Vanguard funds and managed accounts and that no single outside person holds more than 5% of the class. The filing is signed by Ashley Grim on 04/29/2026.
Healthpeak Properties Inc — The Vanguard Group filed Amendment No. 18 to a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of the common stock. The filing explains an internal realignment effective January 12, 2026, that disaggregated certain Vanguard subsidiaries' holdings.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026. It states that Vanguard and related entities have the right to receive dividends or sale proceeds for accounts reported, and that no single other person holds more than 5% of the class.
Healthpeak Properties, Inc. amended several credit agreements in connection with the Janus Living, Inc. IPO. The company added a new $400.0 million senior unsecured delayed draw term loan facility with a five-year maturity and increased maximum aggregate borrowing capacity under its term loan credit agreement from $1.5 billion to $2.0 billion.
Loans under the new facility bear interest at a base rate or SOFR-based rates plus a margin tied to Healthpeak OP’s debt ratings, initially 0.00% for base rate loans and 0.80% for Term SOFR and Daily SOFR loans. After these changes, unused borrowing capacity under the term loan agreement, including the delayed draw commitments, was $750.0 million.
Janus Living, Inc. insiders have reported their initial ownership positions. Entities associated with the company indirectly hold 75,917,780 OP Units in Janus Living OP, LLC, which are linked one-for-one to Class A-1 Common Stock. Janus Member LLC also indirectly holds 138,816,246 shares of Class A-1 Common Stock and 75,917,780 shares of Class A-2 Common Stock, reflecting substantial voting and economic interests.
Healthpeak Properties, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on three items: electing nine directors, approving 2025 executive compensation on an advisory basis, and ratifying Deloitte & Touche LLP as independent auditor for 2026.
The company, an S&P 500 healthcare REIT focused on lab, outpatient medical, and senior housing real estate, highlights 2025 Nareit FFO of $1.81 per share, Diluted FFO as Adjusted of $1.84 per share, 4% merger‑combined same‑store cash (adjusted) NOI growth, and a $1.22 annualized dividend per share with a 7% yield. Net debt to Adjusted EBITDAre averaged 5.2x in 2025.
The proxy emphasizes an independent Board (with an independent Chair), committee refreshment, a 15‑year director term limit, proxy access, and strong attendance. Executive pay is positioned as pay‑for‑performance, using base salary, a STIP tied mainly to normalized FFO per share and leverage, and a largely performance‑based LTIP driven by relative total stockholder return from 2025–2027.
Healthpeak Properties, Inc. filed a report stating that its President and Chief Executive Officer, Scott Brinker, is scheduled to present at the Citi 2026 Global Property CEO Conference on March 3, 2026, at 9:35 a.m. Eastern Time.
A live webcast of the presentation will be accessible through the investor relations section of Healthpeak’s website, where the accompanying presentation materials will also be posted on February 27, 2026. A replay of the presentation will remain available on the website through March 2, 2027, giving investors and other interested parties extended access.
Alonso Lisa A reported disposition transactions in a Form 4 filing for DOC. The filing lists transactions totaling 1,303 shares at a weighted average price of $16.70 per share. Following the reported transactions, holdings were 22,271 shares.
Healthpeak Properties, Inc. director Thomas John T reported routine equity compensation and related tax withholding transactions. On February 6, 2026, he received 23,739 shares of common stock as an award with a reported price of $0, increasing his directly held stake to 835,122 shares. A footnote explains these are restricted stock units that vest in full on the anniversary of the February 6, 2026 grant date.
On February 7, 2026, 6,454 shares were forfeited at $16.85 per share to satisfy tax withholding obligations tied to vesting of restricted stock units granted on February 7, 2025, leaving 828,668 common shares held directly. He also reports 58 shares held indirectly "By Child 7." The forfeiture is explicitly described as not constituting a sale transaction.